SequelSEC

HST Global, Inc. HSTC

Pharmaceutical Preparations · CIK 0000797564 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$0
Fiscal year ended 2024-09-30
Operating income
-$98.12K
Fiscal year ended 2024-09-30
Free cash flow
Unavailable
Fiscal year ended 2024-09-30

HST Global, Inc. (HSTC) reported revenue of $0 and net income of -$101.51K for the fiscal year ended 2024-09-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from HST Global, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Pharmaceutical Preparations.

Income

HST Global, Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2024-09-30
Revenue$0
Cost of revenueUnavailable
Gross profitUnavailable
Operating income-$98.12K
Net income-$101.51K
Research & developmentUnavailable
Weighted-average diluted sharesUnavailable
Pretax incomeUnavailable
Income tax expense$0
Diluted EPSUnavailable
Selling, general & administrativeUnavailable
General & administrative$38.12K
Selling & marketingUnavailable

Balance

HST Global, Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2024-09-30
Cash & equivalents$10.41K
Total assets$1.28M
Current assets$10.41K
Total liabilities$42.08K
Current liabilities$42.08K
Total equity incl. NCI$1.24M
Temporary (mezzanine) equityUnavailable
InventoryUnavailable
Accounts receivableUnavailable
GoodwillUnavailable
Long-term debtUnavailable
Accounts payableUnavailable

Cash flow

HST Global, Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2024-09-30
Operating cash flow-$38.19K
Capital expendituresUnavailable
Investing cash flowUnavailable
Financing cash flow$46.60K
Net change in cashUnavailable
Stock-based compensationUnavailable
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortizationUnavailable

Derived

HST Global, Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2024-09-30
Free cash flowUnavailable
Gross marginUnavailable
Operating marginUnavailable
FCF marginUnavailable
SBC / revenueUnavailable
Current ratio0.25x
Revenue YoY growthUnavailable
Net marginUnavailable
R&D / revenueUnavailable
CapEx / revenueUnavailable
Long-term debt / equityUnavailable
Effective tax rateUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open HSTC in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2024-11-22View SEC filing
10-Q · Filed 2024-08-26View SEC filing
10-Q · Filed 2024-06-05View SEC filing
10-K · Filed 2024-04-05View SEC filing
10-Q · Filed 2023-11-07View SEC filing
10-Q · Filed 2023-08-11View SEC filing

Companies in the same industry

AAGH AARD ABBV ABCL ABEO ABT ABUS ABVC ACAD ACET ACRS ACRV

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.